FIGS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FIGS is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has improved materially and analyst sentiment is constructive, but the current price trend is still technically weak, there is no fresh news catalyst, and the options market is extremely bullish without confirmation from the chart. For an impatient investor unwilling to wait for a better entry, I would not buy this stock today; hold off until the trend turns up and price reclaims resistance.
FIGS is in a bearish technical setup. The MACD histogram is negative and worsening, the RSI_6 at 27.091 signals weak momentum, and the moving averages are bearish with SMA_200 above SMA_20 above SMA_5. Price at 9.93 is below the pivot at 11.127 and just under S1 at 10.13, with S2 at 9.514 nearby as the next meaningful downside level. This indicates the stock is still trading below key trend confirmation levels, so the current trend is not supportive for a fresh long-term entry.
["Analysts have recently raised price targets materially, showing improving confidence in the company.", "KeyBanc kept an Overweight rating and raised its target to $19.", "Roth Capital kept a Buy rating and raised its target to $18 ahead of Q1 results.", "The options market shows strong bullish positioning with very low put-call ratios.", "Market commentary suggests improving fundamentals and better operating efficiency."]
["No news in the recent week, so there is no immediate event-driven catalyst.", "The technical trend remains bearish with negative momentum.", "The stock is still below key resistance/pivot levels.", "Morgan Stanley\u2019s Equal Weight rating implies the upside may already be partially priced in.", "Hedge funds and insiders are both neutral, with no notable buying trend.", "No recent congress trading data or influential figure transactions were reported."]
No latest-quarter financial snapshot was provided due to a data error, so I cannot assess the quarter directly. Based on analyst commentary, recent fundamentals appear to be improving, with stronger execution, better operating efficiency, and expectations for another solid quarter. The latest referenced quarter context is Q1 2026 based on the April 22 analyst note ahead of Q1 results.
Analyst sentiment has improved recently. KeyBanc raised its target from $17 to $19 and maintained Overweight. Roth Capital raised its target from $15.50 to $18 and kept Buy. Morgan Stanley also raised its target sharply from $8 to $15, but only maintained Equal Weight, signaling improved fundamentals but concern that valuation is already rich after a strong run. Overall, Wall Street is constructive, but not universally bullish; the pros see improving fundamentals and execution, while the cautious view says the stock has already run a lot and needs sustained growth to justify more upside.
